TY - JOUR
KW - Adult
KW - Anxiety/epidemiology/etiology
KW - Comorbidity
KW - Depression/epidemiology/etiology
KW - Female
KW - Humans
KW - Male
KW - Neuropsychology
KW - Pain Measurement
KW - Predictive Value of Tests
KW - Prevalence
KW - Primary Health Care/statistics & numerical data
KW - Psychological Tests
KW - Psychometrics
KW - Questionnaires
KW - Risk Factors
KW - Somatoform Disorders/complications/epidemiology
KW - South Africa/epidemiology
AU - J. E. Muller
AU - I. Wentzel
AU - D. G. Nel
AU - D. J. Stein
A1 - 
AB - OBJECTIVE: Multisomatoform disorder (MSD) is characterised by > or = 3 medically inexplicable, troublesome physical symptoms, together with a > or = 2-year history of somatisation. The aim of this study was to evaluate the prevalence of depressive and anxiety disorders in a South African sample MSD, and to compare demographic and clinical outcomes in those patients with and without co-morbidity. METHODS: Fifty-one adult outpatients with MSD were recruited from primary care clinics in the Cape Town metropolitan area. Participants were assessed for the presence of co-morbid depressive and anxiety disorders using the Mini Neuropsychiatric Interview-Plus (MINI-Plus). Outcomes included somatic symptom severity, disability, reported sick days and health care visits, pain experience, patient satisfaction with health services, and clinician-experienced difficulty. RESULTS: A current co-morbid depressive disorder was present in 29.4% (N = 15) of patients, and a current co-morbid anxiety disorder in 52.9% (N = 27). MSD patients with a co-morbid depressive disorder (current or lifetime) had significantly higher physical symptom counts, greater functional impairment, higher unemployment rates, more clinician-reported difficulties, and more dissatisfaction with health care services than those without the disorder. A larger number of co-morbid disorders was associated with greater overall disability. CONCLUSION: High rates of co-morbid depressive and anxiety disorders were present in a South African sample of primary care patients with MSD. Not all patients had co-morbidity, which is consistent with the view that MSD should be viewed as an independent disorder. However, co-morbid depressive disorders were associated with increased symptom severity and functional impairment, consistent with previous reports from developing countries, emphasising the importance of comorbidity in MSD.
BT - South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde
C5 - Medically Unexplained Symptoms
CP - 6
CY - South Africa
IS - 6
JF - South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde
N2 - OBJECTIVE: Multisomatoform disorder (MSD) is characterised by > or = 3 medically inexplicable, troublesome physical symptoms, together with a > or = 2-year history of somatisation. The aim of this study was to evaluate the prevalence of depressive and anxiety disorders in a South African sample MSD, and to compare demographic and clinical outcomes in those patients with and without co-morbidity. METHODS: Fifty-one adult outpatients with MSD were recruited from primary care clinics in the Cape Town metropolitan area. Participants were assessed for the presence of co-morbid depressive and anxiety disorders using the Mini Neuropsychiatric Interview-Plus (MINI-Plus). Outcomes included somatic symptom severity, disability, reported sick days and health care visits, pain experience, patient satisfaction with health services, and clinician-experienced difficulty. RESULTS: A current co-morbid depressive disorder was present in 29.4% (N = 15) of patients, and a current co-morbid anxiety disorder in 52.9% (N = 27). MSD patients with a co-morbid depressive disorder (current or lifetime) had significantly higher physical symptom counts, greater functional impairment, higher unemployment rates, more clinician-reported difficulties, and more dissatisfaction with health care services than those without the disorder. A larger number of co-morbid disorders was associated with greater overall disability. CONCLUSION: High rates of co-morbid depressive and anxiety disorders were present in a South African sample of primary care patients with MSD. Not all patients had co-morbidity, which is consistent with the view that MSD should be viewed as an independent disorder. However, co-morbid depressive disorders were associated with increased symptom severity and functional impairment, consistent with previous reports from developing countries, emphasising the importance of comorbidity in MSD.
PP - South Africa
PY - 2008
SN - 0256-9574; 0256-9574
SP - 473
EP - 476
EP - 
T1 - Depression and anxiety in multisomatoform disorder: prevalence and clinical predictors in primary care
T2 - South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde
TI - Depression and anxiety in multisomatoform disorder: prevalence and clinical predictors in primary care
U1 - Medically Unexplained Symptoms
U2 - 18683382
VL - 98
VO - 0256-9574; 0256-9574
Y1 - 2008
ER -